BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33454824)

  • 1. Distinct profiles of multiple co-occurring symptoms in patients with gastrointestinal cancers receiving chemotherapy.
    Lin Y; Bailey DE; Docherty SL; Porter LS; Cooper BA; Paul SM; Kober KM; Hammer MJ; Wright F; Dunn LB; Conley YP; Levine JD; Miaskowski C
    Support Care Cancer; 2021 Aug; 29(8):4461-4471. PubMed ID: 33454824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Co-occurring Morning and Evening Fatigue Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy.
    Lin Y; Bailey DE; Xiao C; Hammer M; Paul SM; Cooper BA; Conley YP; Levine JD; Kober KM; Miaskowski C
    Cancer Nurs; 2024 Jan-Feb 01; 47(1):E28-E37. PubMed ID: 36076314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence.
    Astrup GL; Hofsø K; Bjordal K; Guren MG; Vistad I; Cooper B; Miaskowski C; Rustøen T
    Acta Oncol; 2017 Mar; 56(3):462-470. PubMed ID: 28077018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct morning and evening fatigue profiles in gastrointestinal cancer during chemotherapy.
    Lin Y; Bailey DE; Docherty SL; Porter LS; Cooper B; Paul S; Kober K; Hammer MJ; Wright F; Conley Y; Levine J; Miaskowski C
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e373-e381. PubMed ID: 34049967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congruence Between Latent Class and K-Modes Analyses in the Identification of Oncology Patients With Distinct Symptom Experiences.
    Papachristou N; Barnaghi P; Cooper BA; Hu X; Maguire R; Apostolidis K; Armes J; Conley YP; Hammer M; Katsaragakis S; Kober KM; Levine JD; McCann L; Patiraki E; Paul SM; Ream E; Wright F; Miaskowski C
    J Pain Symptom Manage; 2018 Feb; 55(2):318-333.e4. PubMed ID: 28859882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Distinct Symptom Profiles in Cancer Patients Using a Pre-Specified Symptom Cluster.
    Hammer MJ; Cooper B; Paul SM; Kober KM; Cartwright F; Conley YP; Wright F; Levine JD; Miaskowski C
    J Pain Symptom Manage; 2022 Jul; 64(1):17-27. PubMed ID: 35339613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster.
    Hammer MJ; Cooper BA; Chen LM; Wright AA; Pozzar R; Blank SV; Cohen B; Dunn L; Paul S; Conley YP; Levine JD; Miaskowski C
    Support Care Cancer; 2023 Jul; 31(8):485. PubMed ID: 37480403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Sleep Disturbance Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy.
    Lin Y; Bailey DE; Docherty SL; Porter LS; Cooper BA; Paul SM; Hammer MJ; Conley YP; Levine JD; Miaskowski C
    Cancer Nurs; 2022 Mar-Apr 01; 45(2):E417-E427. PubMed ID: 34183521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct diarrhea profiles during outpatient chemotherapy.
    Diaz R; Kober KM; Viele C; Cooper BA; Paul SM; Hammer M; Wright F; Conley YP; Levine JD; Miaskowski C
    Support Care Cancer; 2021 May; 29(5):2363-2373. PubMed ID: 32918132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher stress and symptom severity are associated with worse depressive symptom profiles in patients receiving chemotherapy.
    Oppegaard K; Shin J; Harris CS; Schimmel A; Paul SM; Cooper BA; Levine JD; Conley YP; Hammer M; Dunn L; Kober KM; Miaskowski C
    Eur J Oncol Nurs; 2022 Jun; 58():102031. PubMed ID: 35397404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent Class Analysis Reveals Distinct Subgroups of Patients Based on Symptom Occurrence and Demographic and Clinical Characteristics.
    Miaskowski C; Dunn L; Ritchie C; Paul SM; Cooper B; Aouizerat BE; Alexander K; Skerman H; Yates P
    J Pain Symptom Manage; 2015 Jul; 50(1):28-37. PubMed ID: 25647419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy.
    Miaskowski C; Cooper BA; Melisko M; Chen LM; Mastick J; West C; Paul SM; Dunn LB; Schmidt BL; Hammer M; Cartwright F; Wright F; Langford DJ; Lee K; Aouizerat BE
    Cancer; 2014 Aug; 120(15):2371-8. PubMed ID: 24797450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles.
    Morse L; Kober KM; Viele C; Cooper BA; Paul SM; Conley YP; Hammer M; Levine JD; Miaskowski C
    Support Care Cancer; 2021 Dec; 29(12):7985-7998. PubMed ID: 34218321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct symptom experiences in subgroups of patients with COPD.
    Christensen VL; Rustøen T; Cooper BA; Miaskowski C; Henriksen AH; Bentsen SB; Holm AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1801-9. PubMed ID: 27536092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disturbance and decrements in morning energy contribute to a higher symptom burden in oncology patients.
    Davis JK; Mark S; Mackin L; Paul SM; Cooper BA; Conley YP; Hammer MJ; Levine JD; Miaskowski C
    Sleep Med; 2023 Aug; 108():124-136. PubMed ID: 37354746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.
    Tejada M; Viele C; Kober KM; Cooper BA; Paul SM; Dunn LB; Hammer MJ; Wright F; Conley YP; Levine JD; Miaskowski C
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31361899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worse Depression Profiles Are Associated With Higher Symptom Burden and Poorer Quality of Life in Patients With Gynecologic Cancer.
    Calvo-Schimmel A; Hammer MJ; Wright AA; Blank SV; Cohen B; Harris C; Shin J; Conley Y; Paul S; Cooper B; Levine JD; Miaskowski C
    Cancer Nurs; 2024 Jan; ():. PubMed ID: 38259059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study.
    Röhrl K; Guren MG; Astrup GL; Småstuen MC; Rustøen T
    Eur J Oncol Nurs; 2020 Feb; 44():101679. PubMed ID: 31751848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Wound Healing and Quality-of-Life Outcomes in Subgroups of Patients With Venous Leg Ulcers With Different Symptom Cluster Experiences.
    Finlayson K; Miaskowski C; Alexander K; Liu WH; Aouizerat B; Parker C; Maresco-Pennisi D; Edwards H
    J Pain Symptom Manage; 2017 May; 53(5):871-879. PubMed ID: 28063868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.
    Miaskowski C; Cooper BA; Aouizerat B; Melisko M; Chen LM; Dunn L; Hu X; Kober KM; Mastick J; Levine JD; Hammer M; Wright F; Harris J; Armes J; Furlong E; Fox P; Ream E; Maguire R; Kearney N
    Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 26777053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.